| Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran I Sharifi, AR FeKri, MR Aflatonian, A Khamesipour, A Nadim, ... The Lancet 351 (9115), 1540-1543, 1998 | 290 | 1998 |
| First generation leishmaniasis vaccines: a review of field efficacy trials S Noazin, F Modabber, A Khamesipour, PG Smith, LH Moulton, K Nasseri, ... Vaccine 26 (52), 6759-6767, 2008 | 241 | 2008 |
| Waste-grass-mediated green synthesis of silver nanoparticles and evaluation of their anticancer, antifungal and antibacterial activity M Khatami, I Sharifi, MAL Nobre, N Zafarnia, MR Aflatoonian Green Chemistry Letters and Reviews 11 (2), 125-134, 2018 | 223 | 2018 |
| A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran AZ Momeni, T Jalayer, M Emamjomeh, A Khamesipour, F Zicker, ... Vaccine 17 (5), 466-472, 1999 | 204 | 1999 |
| Rectangular shaped zinc oxide nanoparticles: Green synthesis by Stevia and its biomedical efficiency M Khatami, HQ Alijani, H Heli, I Sharifi Ceramics International 44 (13), 15596-15602, 2018 | 178 | 2018 |
| Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysis S Noazin, A Khamesipour, LH Moulton, M Tanner, K Nasseri, F Modabber, ... Vaccine 27 (35), 4747-4753, 2009 | 176 | 2009 |
| An observational study on the current distribution of visceral leishmaniasis in different geographical zones of Iran and implication to health policy M Mohebali, GH Edrissian, MR Shirzadi, B Akhoundi, H Hajjaran, Z Zarei, ... Travel medicine and infectious disease 9 (2), 67-74, 2011 | 132 | 2011 |
| Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, 1994-95. I Sharifi, AR Fekri, MR Aflatonian, A Nadim, Y Nikian, A Kamesipour Bulletin of the World Health Organization 76 (3), 289, 1998 | 130 | 1998 |
| Biosynthesis of bimetallic and core–shell nanoparticles: their biomedical applications–a review M Khatami, HQ Alijani, I Sharifi IET nanobiotechnology 12 (7), 879-887, 2018 | 126 | 2018 |
| Antileishmanial and cytotoxic effects of essential oil and methanolic extract of Myrtus communis L. H Mahmoudvand, F Ezzatkhah, F Sharififar, I Sharifi, ES Dezaki The Korean journal of parasitology 53 (1), 21, 2015 | 115 | 2015 |
| Sonographical and serological survey of human cystic echinococcosis and analysis of risk factors associated with seroconversion in rural communities of Kerman, Iran MF Harandi, SS Moazezi, M Saba, F Grimm, H Kamyabi, F Sheikhzadeh, ... Zoonoses and public health 58 (8), 582-588, 2011 | 100 | 2011 |
| Monitoring of insecticides resistance in main malaria vectors in a malarious area of Kahnooj district, Kerman province, southeastern Iran. H Vatandoost, M Mashayekhi, MR Abaie, MR Aflatoonian, AA Hanafi-Bojd, ... Journal of vector borne diseases 42 (3), 100-108, 2005 | 98 | 2005 |
| Leishmanicidal and cytotoxic activities of Nigella sativa and its active principle, thymoquinone H Mahmoudvand, R Tavakoli, F Sharififar, K Minaie, B Ezatpour, ... Pharmaceutical Biology 53 (7), 1052-1057, 2015 | 92 | 2015 |
| A comprehensive review of cutaneous leishmaniasis in kerman province, southeastern iran-narrative review article I Sharifi, MR Aflatoonian, AR Fekri, MH Parizi, AA Afshar, A Khosravi, ... Iranian journal of public health 44 (3), 299, 2015 | 92 | 2015 |
| Emergence of cutaneous leishmaniasis in a border area at south-east of Iran: an epidemiological survey A Fazaeli, B Fouladi, I Sharifi Journal of vector borne diseases 46 (1), 36, 2009 | 91 | 2009 |
| Antileishmanial activity of Peganum harmala extract on the in vitro growth of Leishmania major promastigotes in comparison to a trivalent antimony drug M Mirzaie, SJ Nosratabadi, A Derakhshanfar, I Sharifi Veterinarski arhiv 77 (4), 365-375, 2007 | 89 | 2007 |
| Emergence of a new focus of anthroponotic cutaneous leishmaniasis due to Leishmania tropica in rural communities of Bam district after the earthquake, Iran I Sharifi, S Poursmaelian, MR Aflatoonian, RF Ardakani, M Mirzaei, ... Tropical Medicine & International Health 16 (4), 510-513, 2011 | 87 | 2011 |
| Spatial distribution and molecular identification of Leishmania species from endemic foci of south-eastern Iran F Sharifi, I Sharifi, M Zarean, MH Parizi, MR Aflatoonian, MF Harandi, ... Iranian journal of parasitology 7 (1), 45, 2012 | 84 | 2012 |
| Leishmanicidal Activity of Biogenic Fe3O4 Nanoparticles M Khatami, H Alijani, I Sharifi, F Sharifi, S Pourseyedi, S Kharazi, ... Scientia pharmaceutica 85 (4), 36, 2017 | 79 | 2017 |
| Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran M Bamorovat, I Sharifi, MR Aflatoonian, H Sharifi, A Karamoozian, ... PloS one 13 (2), e0192236, 2018 | 77 | 2018 |
Mehdi BamorovatLeishmaniasis Research Center, Kerman University of Medical SceincesVerified email at kmu.ac.ir